The supply-chain digitisation platform raised the debt and equity financing from a consortium of new and existing investors potentially including several corporates.
Month: January 2020
Notaras extracts herself from XL Innovate
Martha Notaras, previously a partner at XL Innovate, has teamed up with former New York Life Investments executive John Kim at fintech and insurtech-oriented VC fund Brewer Lane Ventures.
Zhu zips from Fosun RZ to Carsome
Juliet Zhu has left Fosun RZ Capital after two years, most recently as director of Southeast Asia, to take the chief financial officer position at automotive e-commerce marketplace Carsome.
Cigna Ventures signs off on two new deals
Cigna’s corporate venturing arm led a $29.5m round for population healthcare management platform Arcadia.io and bumped Buoy Health’s series B up to $20m.
Jimoty looks to jump to public markets
Opt, NTT Docomo, Lilfull, Japan Best Rescue System and Proto Corporation could exit the classified listings platform, which has received approval for a Tokyo IPO.
Weibo weighs in with Ymatou investment
The cross-border e-commerce marketplace has received an undisclosed eight-figure renminbi amount from Weibo, which will help boost its livestreaming capabilities.
Vesta Healthcare rests series A with $30m
CareCentrix, Nationwide and existing backer Kaiser Permanente all chipped in as the homecare support services provider secured $30m.
Bigfoot Medical steps into $45m series C
Abbott has returned for the first close of insulin technology developer Bigfoot Biomedical’s series C round, after backing its $55m series B two years ago.
GHX makes room for Lumere
Spectrum Health and HCA Healthcare both scored exits after medical analytics software provider Lumere was acquired by health software producer GHX.
NewStore nets $20m in funding
Salesforce Ventures participated in a round that lifted the inventory management platform developer’s overall funding to about $130m.
Proeza Ventures produces $50m first fund
Grupo Proeza-backed venture capital firm Proeza Ventures is focusing on mobility technology and has disclosed some early investments.
Kyverna clears series A funding
Antiviral drug maker Gilead is among the investors that have backed the cell therapy startup’s $25m round.
Zipari pins down insurers for series B
Zipari has raised $22.5m from Horizon Healthcare Services and CareFirst BlueCross BlueShield among others to boost its total to $33.9m.
AbSci seeks corporates for series D funding
JSR Life Sciences and its KBI Biopharma unit co-led a $10.4m round for AbSci and have picked up global marketing rights for the biomanufacturing company’s forthcoming product launch.